Please use this identifier to cite or link to this item:
http://111.93.178.142:25000/jspui/handle/123456789/3478Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Kumaravelrajan R. | - |
| dc.date.accessioned | 2026-04-30T07:08:55Z | - |
| dc.date.available | 2026-04-30T07:08:55Z | - |
| dc.date.issued | 2026-04-30 | - |
| dc.identifier.uri | http://111.93.178.142:25000/jspui/handle/123456789/3478 | - |
| dc.description | Vol. 62, No. 2, p42 | en_US |
| dc.language.iso | en | en_US |
| dc.subject | Carvedilol | en_US |
| dc.subject | nanoemulsion | en_US |
| dc.subject | factorial design | en_US |
| dc.subject | QbD | en_US |
| dc.subject | in vivo | en_US |
| dc.title | Formulation development of carvedilol oral self-nanoemulsion concentrate by full factorial design | en_US |
| dc.type | Other | en_US |
| Appears in Collections: | Vol62, No. 2, 2025 | |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.